LIPA and metabolic dysfunction-associated steatotic liver disease: Indeed, by using an antibody towards the C-term of the protein, also Gomaraschi et al. observed that the decrease of LAL activity was not correlated with the decrease of LAL protein both in fat-loaded HepG2 cells and in NAFLD patients.